Project information
Involvement of Czech Translational Medicine Infrastructure to the European Advanced Translational Research Infrastructure in Medicine
(EATRIS-ERIC-CZ)
- Project Identification
- LM2018133
- Project Period
- 1/2020 - 12/2022
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Large Infrastructures for Research, Development and Innovation
- MU Faculty or unit
- Central European Institute of Technology
- Cooperating Organization
-
Institute of Microbiology of the ASCR, v. v. i.
Institute of Experimental Medicine of the ASCR, v. v. i.
Institute of Nuclear Physics
Institute of Macromolecular Chemistry of the ASCR, v. v. i.
Institute of Organic Chemistry and Biochemistry of the ASCR, v. v. i.
Charles University
Palacký University, Olomouc
- Responsible person doc. MUDr. Marián Hajdúch, Ph.D.
In 2011, the Czech Republic acceded to the European Advanced Translational Research Infrastructure in Medicine (EATRIS) consortium and this transitional phase lasted even in 2013. EATRIS entered in fall 2013 to ERIC (EATRIS-ERIC) and the Czech Republic became one of the founding countries. At the national level, the national node was built according to the schedule in 2010-2014 (Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc - IMTM), and in 2013/2014 we have created the national network, where the following institutions joined: Institute of Chemical Technology Prague (ICT), Institute of Organic Chemistry and Biochemistry AS CR, v.v.i. (IOCB), Charles University in Prague, First Faculty of Medicine (CU), Institute of Macromolecular Chemistry AS CR, v.v.i. (IMC), Masaryk University, Central-European Technology Institute (CEITEC), Nuclear Physics Institute of the ASCR, v.v.i. (NPI), Institute of Microbiology AS CR, v.v.i. (IM). Majority of these institutions have already signed an access agreement to EATRIS-ERIC (http://www.eatris.eu/about/simpleinstitutions.html). Czech institutions are actively involved in the activities of platforms Small Molecules, Biomarkers, Vaccines, and Imaging and Tracing. The mission of the current infrastructure project proposal EATRIS-ERIC-CZ is to further develop a dynamic and collaborative environment that will support chemical, biomedical, and clinical research, and speed up its transfer into clinical practice. It will connect and facilitate collaboration of top national research institutions and hospitals in the research partnership. EATRIS-ERIC-CZ will lead to the development of new knowledge and it will place the Czech Republic among nationally and internationally recognized centres of excellence in molecular and translational medicine directly linked to EATRIS-ERIC and other major biomedical infrastructures.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Publications
Total number of publications: 21
2024
-
Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities
Journal of Medicinal Chemistry, year: 2024, volume: 67, edition: 16, DOI
-
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
British journal of haematology, year: 2024, volume: 204, edition: 1, DOI
-
TGF-β induces matrisome pathological alterations and EMT in patient-derived prostate cancer tumoroids
Matrix Biology, year: 2024, volume: 125, edition: January 2024, DOI
2023
-
Klonální hematopoéza neurčitého potenciálu je možná a dosud nepopsaná příčina cévní mozkové příhody
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, year: 2023, volume: 86, edition: 4, DOI
-
Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery
Cancers, year: 2023, volume: 15, edition: 16, DOI
2022
-
Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells
Transplant Immunology, year: 2022, volume: 71, edition: April, DOI
-
Etické zásady pro používání a sdílení genomických dat z výzkumu
Časopis lékařů českých, year: 2022, volume: 161, edition: 7-8
-
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
BMC Cancer, year: 2022, volume: 22, edition: 1, DOI
-
Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture
SCIENTIFIC REPORTS, year: 2022, volume: 12, edition: AQ, DOI
-
Klonální hematopoéza neurčitého potenciálu při ischemické cévní mozkové příhodě - studijní protokol
Ceska a slovenska neurologie a neurochirurgie, year: 2022, volume: 85, edition: 6, DOI